Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health (NYSE: ELV), one of America's largest health insurers, generates news that reflects its position at the intersection of healthcare policy, insurance markets, and medical innovation. As the parent company of multiple Blue Cross Blue Shield plans serving tens of millions of members, Elevance Health's announcements carry significant implications for employers, healthcare providers, and policyholders across the country.
News coverage for Elevance Health typically spans several key areas. Quarterly and annual earnings reports reveal performance across its Commercial, Government, CarelonRx, and Carelon Services segments. Medicare and Medicaid program updates reflect the company's substantial role in administering government healthcare coverage. Partnership announcements often highlight collaborations with healthcare providers, community organizations, and technology companies aimed at improving care delivery and member outcomes.
The company's expansion into healthcare services through Carelon generates coverage of behavioral health initiatives, pharmacy benefit management developments, and specialized care programs. Digital health investments produce announcements about virtual care tools, mobile applications, and member engagement platforms that shape how millions of Americans access healthcare information and services.
Board governance news, credit rating actions, and regulatory developments affecting health insurance markets also appear regularly in Elevance Health's news stream. For investors, employers evaluating health plan options, and healthcare industry observers, tracking Elevance Health news provides insight into trends shaping American healthcare delivery and financing.
Elevance Health (NYSE: ELV) will announce its second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. The domestic access number for the call is 888-947-9963 with the access code 3972058, and for international participants, the number is 312-470-0178 with the same access code. A replay of the call will be available domestically at 800-391-9851 and internationally at 203-369-3268 from 11:30 a.m. EDT on July 17 until August 17, 2024. Additionally, the call will be accessible via a live webcast on the Elevance Health website under the 'Investors' section.
Elevance Health (NYSE: ELV) will present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. EDT. Senior management will deliver the presentation, which will be webcast live on the company's investor relations website. A replay of the presentation will be available for 90 days following the event. Interested individuals are advised to visit the website early to download any necessary software. This presentation will reflect Elevance Health's recent SEC filings, including their Annual Report on Form 10-K for the year ending December 31, 2023.
Elevance Health (NYSE: ELV) announced its participation in Bernstein's 40th Annual Strategic Decisions Conference in New York City on May 31 at 9:00 a.m. EDT.
Senior management will present critical company updates. Interested parties can access a live webcast through Elevance Health's investor site.
A replay will be available for 90 days post-presentation.
Listeners are advised to review Elevance Health's recent SEC filings, including the 2023 Annual Report on Form 10-K.
FAQ
What is the current stock price of Elevance Health (ELV)?
What is the market cap of Elevance Health (ELV)?
